Induced CAR-Macrophages as a Novel Therapeutic Cell Type for Cancer Immune Cell Therapies

The Chimeric antigen receptor (CAR)-T cell therapy has made inroads in treating hematological malignancies. Nonetheless, there are still multiple hurdles in CAR-T cell therapy for solid tumors. Primary CAR-expressing macrophage cells (CAR-Ms) and induced pluripotent stem cells (iPSCs)-derived CAR-ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Siyu, Lei, Anhua, Wang, Xudong, Lu, Hengxing, Wang, Shuhang, Yang, Yuqi, Li, Ning, Zhang, Yi, Zhang, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139529/
https://www.ncbi.nlm.nih.gov/pubmed/35626689
http://dx.doi.org/10.3390/cells11101652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139529/
https://www.ncbi.nlm.nih.gov/pubmed/35626689
http://dx.doi.org/10.3390/cells11101652

Ejemplares similares